NO992436L - N(imidazolylbutyl)benzensulfonamidderivater, deres fremstilling og terapeutiske anvendelse - Google Patents

N(imidazolylbutyl)benzensulfonamidderivater, deres fremstilling og terapeutiske anvendelse

Info

Publication number
NO992436L
NO992436L NO992436A NO992436A NO992436L NO 992436 L NO992436 L NO 992436L NO 992436 A NO992436 A NO 992436A NO 992436 A NO992436 A NO 992436A NO 992436 L NO992436 L NO 992436L
Authority
NO
Norway
Prior art keywords
alkyl
therapeutic use
imidazolylbutyl
preparation
benzenesulfonamide derivatives
Prior art date
Application number
NO992436A
Other languages
English (en)
Other versions
NO992436D0 (no
Inventor
Jean-Michel Altenburger
Gilbert Lassalle
Valurie Martin
Daniel Galtier
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo filed Critical Synthelabo
Publication of NO992436D0 publication Critical patent/NO992436D0/no
Publication of NO992436L publication Critical patent/NO992436L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/68—Halogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Oppfinnelsene vedrører forbindelser med formel (I) hvor R, og R'j, representerer hydrogen, halogen eller (C1-C4) alkyl, R2 representerer en 1-piperidin-l-yl gruppe, 1,2,3,6-tetrahydro- pyridin-1-yl som eventuelt er substituert, heksahydro-lH- azepin-1-yl, heptahydroazocin-1-yl, oktahydro-lH-azonin-1-yl, (a) (a-B = -CONR"), m = l til 2 og p = l til 2), (b) (Q er karbon eller nitrogen, D = (C-^-C^) alkyl eller -CH2CF3 .og r = l til 3, R3 representerer (C-^-C^ alkyl, -COR5 [R5 er (C^-C,,) - alkyl, -(CH2)nOCH3, -CH2O(C2H4O)nCH3, -(CH2)nCF3, -(CH2)nOH (n = l til 4)], -S02R6, -CONHRg, -SO2N{R6)2 (R6 er (C1-C4)- alkyl), R4 representerer hydrogen eller halogen og A repre- senterer fenyl eller heterosyklus som eventuelt er substi- tuert eller cyklo(C5-C8)alkyl. Forbindelsene har terapeutisk anvendelse.
NO992436A 1996-11-22 1999-05-20 N(imidazolylbutyl)benzensulfonamidderivater, deres fremstilling og terapeutiske anvendelse NO992436L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9614309A FR2756285B1 (fr) 1996-11-22 1996-11-22 Derives de n-(imidazolylbutyle)benzenesulfonamide, leur preparation et leur application en therapeutique
PCT/FR1997/002079 WO1998022443A1 (fr) 1996-11-22 1997-11-19 Derives de n-(imidazolylbutyle) benzenesulfonamide ayant une activite antithrombotique

Publications (2)

Publication Number Publication Date
NO992436D0 NO992436D0 (no) 1999-05-20
NO992436L true NO992436L (no) 1999-07-22

Family

ID=9497920

Family Applications (1)

Application Number Title Priority Date Filing Date
NO992436A NO992436L (no) 1996-11-22 1999-05-20 N(imidazolylbutyl)benzensulfonamidderivater, deres fremstilling og terapeutiske anvendelse

Country Status (20)

Country Link
EP (1) EP0946517A1 (no)
JP (1) JP2001504128A (no)
KR (1) KR20000069063A (no)
CN (1) CN1238765A (no)
AR (1) AR009627A1 (no)
AU (1) AU5226498A (no)
BG (1) BG103414A (no)
BR (1) BR9713291A (no)
CA (1) CA2270478A1 (no)
CO (1) CO4910158A1 (no)
CZ (1) CZ178299A3 (no)
EE (1) EE9900201A (no)
FR (1) FR2756285B1 (no)
HU (1) HUP9904599A2 (no)
IL (1) IL129546A0 (no)
NO (1) NO992436L (no)
SK (1) SK66799A3 (no)
TR (1) TR199901143T2 (no)
WO (1) WO1998022443A1 (no)
ZA (1) ZA9710515B (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2783521B1 (fr) * 1998-09-18 2002-04-26 Synthelabo Derives de n-(arginyl) benzenesulfonamide, leur preparation et leur application en therapeutique
FR2806722B1 (fr) * 2000-03-23 2002-05-17 Sanofi Synthelabo Derives de n-(heterocyclylbutyl) benzene-ou pyridine sulfonamide, leur preparation et leur application en therapeutique
EP3201168B1 (en) 2014-09-29 2020-03-18 Cellix Bio Private Limited Compounds and compositions for the treatment of multiple sclerosis

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2689130B1 (fr) * 1992-03-30 1994-05-27 Synthelabo Derives de 1-[2 (arylsulfonylamino)ethyl-1-oxo] piperidine, leur preparation et leur application en therapeutique.
FR2710066B1 (fr) * 1993-09-14 1995-10-20 Synthelabo Dérivés de 1-[2-amino-5-[1-(triphénylméthyl-1H-imidazol-4-yl]-1-oxopentyl]piperidine, leur préparation et leur utilisation comme intermédiaires de synthèse.
FR2727410B1 (fr) * 1994-11-25 1996-12-20 Synthelabo Chlorures de sulfonyles, leur preparation et leur utilisation comme intermediaires de synthese
FR2728570B1 (fr) * 1994-12-23 1997-04-11 Synthelabo Derives de 1-oxo-2-(phenylsulfonylamino)pentylpiperidine, leur preparation et leur application en therapeutique
DE19548797A1 (de) * 1995-12-27 1997-07-03 Thomae Gmbh Dr K Substituierte 2-Amino-imidazole, ihre Herstellung und ihre Verwendung als Arzneimittel

Also Published As

Publication number Publication date
ZA9710515B (en) 1998-06-10
NO992436D0 (no) 1999-05-20
WO1998022443A1 (fr) 1998-05-28
HUP9904599A2 (hu) 2000-06-28
SK66799A3 (en) 2000-02-14
CZ178299A3 (cs) 1999-08-11
TR199901143T2 (xx) 1999-08-23
AU5226498A (en) 1998-06-10
FR2756285A1 (fr) 1998-05-29
JP2001504128A (ja) 2001-03-27
CA2270478A1 (en) 1998-05-28
KR20000069063A (ko) 2000-11-25
AR009627A1 (es) 2000-04-26
IL129546A0 (en) 2000-02-29
CO4910158A1 (es) 2000-04-24
EE9900201A (et) 1999-12-15
EP0946517A1 (fr) 1999-10-06
CN1238765A (zh) 1999-12-15
BG103414A (en) 2000-01-31
FR2756285B1 (fr) 1998-12-18
BR9713291A (pt) 1999-10-26

Similar Documents

Publication Publication Date Title
HUP0100225A2 (hu) Karboxamido-tiazol-származékok, előállításuk és az ezeket tartalmazó gyógyszerkészítmények
TW326447B (en) Substituted 2-phenylpyridines, intermediates and process for their preparation and application thereof
HUP0102563A2 (hu) Indolszármazékok és alkalmazásuk rosszindulatú és egyéb, patológiás sejtproliferáción alapuló megbetegedések kezelésére
HUP0101204A2 (hu) HIV-gátló pirimidinszármazékok és a vegyületeket tartalmazó gyógyászati készítmények
HUP0002072A2 (hu) N-([1,2,4]-triazoloazinil)-benzol-és -piridin-szulfonamid-származékok, intermedierjeik, herbicid készítmények és alkalmazásuk
HUP0402376A2 (hu) Imidazol-4-karboxamid-származékok, előállításuk és az ezeket tartalmazó, elhízás kezelésére alkalmas gyógyszerkészítmények
ATE261444T1 (de) Pyrazolopyridine
HUP0100601A2 (hu) N-tartalmú biciklusos vegyületek, eljárás előállításukra és ezeket tartalmazó gyógyszerkészítmények
HUP0401335A2 (hu) Herbicid hatású [(piridil-propinil)-oxi]-fenil-származékok, előállításuk és alkalmazásuk
HUP0302367A2 (hu) HIV Integráz inhibitorokként hasznos aza- és poliazanaftalenil-karboxamidok, ezeket tartalmazó gyógyszerkészítmények
HUP0301243A2 (hu) Herbicid hatású szubsztituált piridin-ketonok, előállításuk és alkalmazásuk
NZ333727A (en) Substituted pyrido- or pyrimido-containing 6,6- or 6,7-bicyclic arylsulfonylamino hydroxamic acid derivatives
IS6939A (is) Pýrasól afleiður til meðhöndlunar á HIV-smiti
NO973635L (no) Fremgangsmåte for hemming av celle-celle adhesjon
HUP9902410A2 (hu) Amidinszármazékok, előállításuk, trombininhibitorként való alkalmazásuk, a vegyületeket tartalmazó gyógyászati készítmények
NO20044501L (no) [1,4] diazenino [6,7,1-IJ] kinolin-derivater som antipsykotis og antifedme-midler
NO954453L (no) Nye pyridin-, pyrimidin- og benzenderivater som adreno-ceptorantagonister
FR2619111B1 (fr) Derives de (piperidinyl-4)methyl-2 tetrahydro-1,2,3,4 9h-pyrido (3,4-b) indole, leur preparation et leur application en therapeutique
DK0518819T3 (da) Amidino-forbindelser, deres fremstilling og anvendelse som lægemiddel
NO903941L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive diazepinon-derivater.
DK0424244T3 (da) 3-aryl-oxazolidinon-derivater, fremgangsmåde til fremstilling deraf og terapeutisk anvendelse deraf
WO2003008412A3 (en) Hetero-bicyclic crf antagonists
NO983178L (no) Anvendelse av 3,4-difenylkromaner til fremstilling av et farmasaytisk preparat for behandling eller profylakse av menopausesymptomer
NO992436L (no) N(imidazolylbutyl)benzensulfonamidderivater, deres fremstilling og terapeutiske anvendelse
DK300890A (da) Kondenserede pyrazol-3-oxo-propannitrilderivater og fremgangsmaade til fremstilling deraf

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application